...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: American Association for Cancer Research 2019

Meeting today till April 1st, last presentation mentions first compani to present joint BETi results.  Anybody know more, what day, is this joint with Pfizer?

thx

Share
New Message
Please login to post a reply